These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38770589)

  • 1. Viral Testing for Febrile Infants Without Procalcitonin Measurement.
    Wolek C; Poirier C; Yannopoulos A; Kuppermann N; Burstein B
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38770589
    [No Abstract]   [Full Text] [Related]  

  • 2. Procalcitonin Use After Clinical Practice Guideline and QI Intervention for Febrile Infants.
    Shine A; Bryan M; Brown M; Aronson PL; McDaniel CE
    Hosp Pediatr; 2024 Oct; 14(10):e455-e457. PubMed ID: 39295527
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients.
    England JT; Del Vecchio MT; Aronoff SC
    J Emerg Med; 2014 Dec; 47(6):682-8. PubMed ID: 25281186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Febrile Infant Algorithms by Duration of Fever.
    Velasco R; Gomez B; Labiano I; Mier A; Ugedo A; Benito J; Mintegi S
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38563061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin in young febrile infants for the detection of serious bacterial infections.
    Maniaci V; Dauber A; Weiss S; Nylen E; Becker KL; Bachur R
    Pediatrics; 2008 Oct; 122(4):701-10. PubMed ID: 18829791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum procalcitonin concentration in the evaluation of febrile infants 2 to 60 days of age.
    Woelker JU; Sinha M; Christopher NC; Powell KR
    Pediatr Emerg Care; 2012 May; 28(5):410-5. PubMed ID: 22531197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin levels in febrile infants after recent immunization.
    Dauber A; Weiss S; Maniaci V; Nylen E; Becker KL; Bachur R
    Pediatrics; 2008 Nov; 122(5):e1119-22. PubMed ID: 18977961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Procalcitonin and early-onset seizures: When do we offer a higher diagnostic yield?].
    Muñoz Aguilar G; Domingo Triadó I; Benito M; Montesinos Sanchis E
    An Pediatr (Barc); 2015 Jul; 83(1):58-60. PubMed ID: 26006270
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: A prospective observational study.
    Xu XJ; Luo ZB; Xia T; Song H; Yang SL; Xu WQ; Ni YR; Ning Zhao ; Tang YM
    Cytokine; 2019 Apr; 116():1-6. PubMed ID: 30684912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the Febrile Young Infant: Update for the 21st Century.
    Woll C; Neuman MI; Aronson PL
    Pediatr Emerg Care; 2017 Nov; 33(11):748-753. PubMed ID: 29095773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days.
    Widmer K; Schmidt S; Bakel LA; Cookson M; Leonard J; Tyler A
    Hosp Pediatr; 2021 Mar; 11(3):223-230. PubMed ID: 33597148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement.
    Burstein B; Alathari N; Papenburg J
    Pediatrics; 2022 Jun; 149(6):. PubMed ID: 35578916
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated serum procalcitonin predicts Gram-negative bloodstream infections in patients with burns.
    Lin JC; Chen ZH; Chen XD
    Burns; 2020 Feb; 46(1):182-189. PubMed ID: 31859083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of C reactive protein and procalcitonin in the diagnosis of lower respiratory tract infection in children in the outpatient setting.
    Pérez-López A; Irwin A; Rodrigo C; Prat-Aymerich C
    BMJ; 2021 Jun; 373():n1409. PubMed ID: 34117023
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of the Feverkidstool and procalcitonin for detecting serious bacterial infections in febrile children.
    Nijman RG; Vergouwe Y; Moll HA; Smit FJ; Weerkamp F; Steyerberg EW; van der Lei J; de Rijke YB; Oostenbrink R
    Pediatr Res; 2018 Feb; 83(2):466-476. PubMed ID: 29116239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study.
    Waterfield T; Maney JA; Hanna M; Fairley D; Shields MD
    BMC Pediatr; 2018 Dec; 18(1):387. PubMed ID: 30541505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study.
    Park JS; Byun YH; Lee JY; Lee JS; Ryu JM; Choi SJ
    BMC Pediatr; 2021 Mar; 21(1):109. PubMed ID: 33663442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using procalcitonin levels to predict infection and reduce unnecessary antibiotic usage in febrile children aged 3-36 months.
    Thongsamer P; Laoprasopwattana K
    J Infect Dev Ctries; 2022 Sep; 16(9):1445-1449. PubMed ID: 36223620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.